QuarterHawk — Equity ResearchQuarterHawk — Equity Research

Varex Imaging Corporation (VREX)

Healthcare

No action
Fundamental
3
Sentiment
3
Technical
3

Do Nothing: ATR14 0.15 is 0.81% of price, below the 1.0% minimum — the stock is pinned in an 18.45–18.63 deal range and too range-compressed for any entry to reach an ATR-scaled target; neither a pullback limit (no support depth below the pin) nor a breakout stop (0.05 daily range vs 0.075 minimum risk) qualifies.

Analysis as of 2026-09-21· more than 2 trading days ago

Company overview

Varex Imaging Corporation specializes in developing and producing X-ray imaging components, divided into Medical and Industrial segments. The Medical segment offers X-ray tubes, digital detectors, and software for diagnostic imaging, while the Industrial segment provides X-ray technology for security and industrial inspection. The company operates globally and is headquartered in Salt Lake City, Utah.

Fundamental

fair
Fundamental3
Modest profitability

Varex shows steady revenue and modest profitability, but cash flow is weak and leverage is moderate.

Varex has steady but slow revenue, modest trailing profitability (gross margin ~34%, EBITDA margin ~10%) and moderate balance-sheet leverage (net debt/EBITDA ~3.2; interest coverage ~1.9). Cash conversion is currently weak (trailing free cash flow negative), and valuation is largely event-driven by the announced $18.90/share cash acquisition, shifting the thesis from operating upside to deal-completion risk and timing.

Sentiment

fair
Sentiment3
Merger-arb setup

Sentiment is driven by the announced Teledyne acquisition, with limited upside until deal completion.

The dominant catalyst is the announced Teledyne all-cash acquisition of Varex at $18.90/share (announced 2026-08-10, close expected early 2027, confidence: announced) — a genuinely market-rewarded event that has left the stock ~2.4% below the offer with no forward-dated driver; sentiment delta is determinate but cooling (baseline +0.63 → +0.08 as deal-euphoria coverage thinned into flat-positive consolidation), retail chatter is effectively absent, and the red-flag screen is clean with no cap applied — a priced-in, mixed merger-arb setup.

Technical

fair
Technical3
Range-compressed

The stock is pinned in a narrow range, limiting trading opportunities due to low volatility.

Bullish longer-frame structure — price 18.47 well above SMA50 (15.57) and SMA200 (12.69) with ADX ~69.6 — but the advance is a single 2026-08-10 gap event (~12.4 to ~18.4 on 13.2M shares) followed by a six-week pin at 18.45–18.63: ATR14 has collapsed to 0.15 (0.81% of price), RSI14 82.16 is extreme overbought, and MACD (0.67 line below 0.91 signal, histogram -0.24) is decelerating. Mixed read — one strong frame (trend), two weak frames (momentum, volatility) — score 3. Trade blocked by the minimum-ATR floor: no entry can reach an ATR-scaled target from a tape that ranges 0.03–0.05 per session.

You’re looking at 2026-09-21 — more than 2 trading days ago.

Subscribers saw this then, and see today’s score, verdict and trade plan now.

Not financial advice. For informational and educational purposes only.